Related Experiment Video
Updated: May 29, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Probiotics and the Risk of Infection
1Department of Pediatrics, Duke University, 2400 Pratt Street, DUMC Box 2739, Durham, NC 27705, USA.
Insights
Probiotic use in preterm infants may lower necrotizing enterocolitis risk but carries a rare risk of infection. This review covers probiotic infection risks, benefits, and pathophysiology in neonatal intensive care units.
Area of Science:
- Neonatal medicine
- Microbiology
- Pediatric gastroenterology
Background:
- Probiotic use is rising in preterm infants, potentially reducing necrotizing enterocolitis.
- Probiotic-associated infections are a serious concern in neonatal intensive care units.
- A recent case and FDA action highlight the risks of probiotic supplementation.
Purpose of the Study:
- To discuss the epidemiology and pathophysiology of invasive infections linked to probiotics in preterm infants.
- To review the benefits and risks of probiotic use in this vulnerable population.
- To provide an overview as regulations and products evolve.
Main Methods:
- Literature review of probiotic use in preterm infants.
- Analysis of reported cases of probiotic-associated infections.
- Discussion of epidemiological and pathophysiological data.
Main Results:
- Invasive infection is an infrequent but recognized risk of probiotic supplementation.
- Understanding the pathophysiology is crucial for risk mitigation.
- Balancing benefits and risks is essential for clinical decision-making.
Conclusions:
- Probiotic supplementation in preterm infants requires careful consideration of infection risks.
- Ongoing research and regulatory oversight are necessary.
- Informed clinical practice is key to optimizing outcomes.
Abstract:
Probiotic use has increased in preterm infants and may reduce the risk of necrotizing enterocolitis. Probiotic-associated infection is a concern for infants receiving probiotic supplementation in the neonatal intensive care unit, as highlighted by a recent case and subsequent action by the United States Food and Drug Administration. Based on reports to date, invasive infection is an infrequent but known risk of probiotic supplementation. In this article, we discuss the epidemiology and pathophysiology of invasive infection in preterm infants, review the benefits and risks of probiotic as regulations and available products continue to evolve.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

